2seventy bio, Inc.

Ownership Transactions Reported by 18 Insiders

Symbol
TSVT on Nasdaq
Industry
Pharmaceutical Preparations
Location
60 Binney Street, Cambridge, MA

Insiders trading volume in the past year

2seventy bio, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Kynam Capital Management, LP 10%+ Owner $61.3M Aug 10, 2023
Kynam Global Healthcare Master Fund, LP 10%+ Owner $61.3M Aug 10, 2023
Casdin Capital, LLC Director $12.9M +$3.81M +41.9% Jun 10, 2024
Nick Leschly President and CEO, Director $7.01M -$286K -3.91% Jan 5, 2024
William D. Baird III President and CEO, Director $4.04M -$135K -3.24% Jul 1, 2024
Philip D. Gregory Chief Scientific Officer $1.79M -$102K -5.4% Jan 5, 2024
Victoria Eatwell Chief Financial Officer $1.69M -$4.98K -0.29% Aug 5, 2024
Jessica Snow Title: Senior Vice President of Quality and Enabling Functions $921K -$36.6K -3.82% Aug 14, 2024
Nicola Heffron Chief Operating Officer $335K Feb 7, 2023
Wei Lin Director $232K Jun 10, 2024
Denice Torres Director $227K Jun 10, 2024
Marcela V. Maus Director $210K Jun 10, 2024
Sarah Glickman Director $210K Jun 10, 2024
Daniel Lynch Director $145K Jun 13, 2023
Charles W. Newton Director $142K Jun 10, 2024
Ramy Ibrahim Director $138K Jun 13, 2023
William R. Sellers Director $24.7K Nov 11, 2021
bluebird bio, Inc. 10%+ Owner Nov 3, 2021

Recent Insider Transactions by Companies or Individuals for 2seventy bio, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.